Western Europe Medical Cannabis Market, by Product Type, 2018-2027

Growth Outlook

• The 2027 portion of the Western Europe Medical Cannabis Market, by Product Type, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 4828 Mn in 2026 and is projected to reach USD 6097 Mn by 2027 — a gain of about 26% over the forecast period, translating to a CAGR in the double digits.
• The Western Europe medical cannabis market has witnessed significant growth in recent years, due to the increasing demand for alternative and natural treatments for various medical conditions. Medical cannabis, also known as medical marijuana, is derived from the cannabis plant and is used to treat a wide range of ailments such as chronic pain, anxiety, epilepsy, and multiple sclerosis.
• What the regional split looks like (2026): Dissolvables/Powders leads, holding roughly 44% of segment value — the single largest regional share. Oil is the second-largest contributor. Solids and Ointments & Creams make up the remainder, in descending order.
• By 2027, Dissolvables/Powders alone is expected to reach USD 2674 Mn, with Oil at USD 2187 Mn.

Market Dynamics

The Western Europe medical cannabis market has witnessed significant growth in recent years, due to the increasing demand for alternative and natural treatments for various medical conditions. Medical cannabis, also known as medical marijuana, is derived from the cannabis plant and is used to treat a wide range of ailments such as chronic pain, anxiety, epilepsy, and multiple sclerosis. It is available in various forms such as oils, tinctures, capsules, and dried flowers. One of the most popular product types in the Western Europe medical cannabis market is oils. These oils are typically derived from the cannabis plant through an extraction process and can be ingested orally or applied topically. Oils offer a convenient and discreet way of consuming medical cannabis, making it a preferred choice for patients who do not wish to smoke or vaporize the product. They also allow for precise dosing, which is important for medical conditions that require specific amounts of the drug. Another popular product type in the Western Europe medical cannabis market is tinctures. Similar to oils, tinctures are also derived from the cannabis plant through an extraction process. However, tinctures are typically alcohol-based and are administered sublingually (under the tongue).

This method allows for quick absorption into the bloodstream, making it ideal for patients who require immediate relief from their symptoms. Capsules are also gaining traction in the Western Europe medical cannabis market. They offer a convenient and easy way of consuming medical cannabis, similar to traditional pharmaceutical drugs. This form of medical cannabis is especially appealing to elderly patients who may have difficulty swallowing or those who prefer a more discreet method of ingestion. Dried flowers, also known as buds or herb, are the most commonly recognized form of cannabis. They are typically smoked or vaporized and provide immediate relief of symptoms. However, due to the health risks associated with smoking, this method of consumption may not be suitable for all patients. In addition to the above-mentioned product types, the Western Europe medical cannabis market also offers a variety of other products such as topicals, edibles, and concentrates. These products are gaining popularity among consumers due to their ease of use and customizable dosing options. In conclusion, the Western Europe medical cannabis market offers a diverse range of product types that cater to the needs and preferences of patients.

The increasing demand for alternative and natural treatments for medical conditions is expected to drive the growth of this market in the coming years. As legalization and acceptance of medical cannabis continues to expand across the region, it is likely that we will see continued innovation and development of new product types in the market.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2024.